Motonobu Nakamura

Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma

Ryosuke Hino, Kenji Kabashima, Yu Kato et al. · Cancer · 2010 · 662 citations · Full text

Medicine, Immunology, Oncology +17

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

Yasuhito Hamaguchi, Masataka Kuwana, Kana Hoshino et al. · Archives of Dermatology · 2011 · 330 citations

Life Sciences, Dermatology, Immunology +11

High frequency class switching of an lgM⁺ B lymphoma clone CH12F3 to lgA⁺ cells

Motonobu Nakamura, Shigeru Kondo, Manabu Sugai et al. · International Immunology · 1996 · 236 citations

Life Sciences, Immunology, Molecular Biology +17

Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study

Iwao Nakabayashi, Motonobu Nakamura, Koji Kawakami et al. · Nephrology Dialysis Transplantation · 2010 · 212 citations

Medicine, Nephrology, Pharmacology +16